• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中的长链非编码RNA:是友是敌?

Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?

作者信息

Soltanieh Sina Kalantari, Khastar Sahar, Kaur Irwanjot, Kumar Abhishek, Bansal Jaya, Fateh Ata, Nathiya Deepak, Husseen Beneen, Rajabivahid Mansour, Dehghani-Ghorbi Mahmoud, Akhavan-Sigari Reza

机构信息

MVZ Labor Synlab Berlin, Berlin, Germany.

Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Cell Biochem Biophys. 2025 Mar;83(1):279-294. doi: 10.1007/s12013-024-01555-8. Epub 2024 Oct 8.

DOI:10.1007/s12013-024-01555-8
PMID:39377981
Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a range of conditions that start with the accumulation of fat in the liver (hepatic steatosis) and can progress to more severe stages like steatohepatitis (NASH) and fibrosis without drinking alcohol. Environmental and genetic variables both contribute to MAFLD's development, with various biological processes and mediators involved at every phase. Long non-coding RNAs (lncRNAs) are a class of RNA molecules that are not translated into protein and are over 200 nucleotides long. They can impact genes that encode protein by controlling transcriptional and post-transcriptional procedures. Dysregulation of lncRNA has been connected to several liver diseases, including MAFLD. Recent research has linked lncRNAs to MAFLD pathology in both patients and animal models. However, the roles of most lncRNAs in MAFLD pathology are still not well recognized. This review provides a comprehensive catalog of recently reported lncRNAs in the pathogenesis of MAFLD and summarizes the current knowledge of lncRNAs usage as therapeutic strategies in MAFLD, the most common liver disease. Collectively, lncRNA's targeting could potentially offer a therapeutic approach by modulating MAFLD.

摘要

代谢功能障碍相关脂肪性肝病(MAFLD)是一系列始于肝脏脂肪堆积(肝脂肪变性)的病症,在无饮酒情况下可进展至更严重阶段,如脂肪性肝炎(NASH)和肝纤维化。环境和遗传变量均对MAFLD的发展有影响,各个阶段涉及多种生物学过程和介质。长链非编码RNA(lncRNA)是一类不翻译成蛋白质且长度超过200个核苷酸的RNA分子。它们可通过控制转录和转录后过程影响编码蛋白质的基因。lncRNA的失调与包括MAFLD在内的多种肝脏疾病有关。最近的研究已将lncRNA与患者和动物模型中的MAFLD病理联系起来。然而,大多数lncRNA在MAFLD病理中的作用仍未得到充分认识。本综述提供了最近报道的MAFLD发病机制中lncRNA的综合目录,并总结了目前关于lncRNA作为最常见肝脏疾病MAFLD治疗策略的知识。总体而言,靶向lncRNA可能通过调节MAFLD提供一种治疗方法。

相似文献

1
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?非酒精性脂肪性肝病中的长链非编码RNA:是友是敌?
Cell Biochem Biophys. 2025 Mar;83(1):279-294. doi: 10.1007/s12013-024-01555-8. Epub 2024 Oct 8.
2
Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis.长链非编码 RNA 参与非酒精性脂肪性肝病向脂肪性肝炎的进展。
Cells. 2021 Jul 25;10(8):1883. doi: 10.3390/cells10081883.
3
Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease.长链非编码 RNA 在非酒精性脂肪性肝病中的进化保守性。
Life Sci. 2021 Jan 1;264:118560. doi: 10.1016/j.lfs.2020.118560. Epub 2020 Oct 10.
4
LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2.LncPRYP4-3 通过靶向 RPS4Y2 作为一种新型诊断生物标志物用于解析代谢相关脂肪性肝病的亚型。
Clin Exp Med. 2020 Nov;20(4):587-600. doi: 10.1007/s10238-020-00636-1. Epub 2020 Jun 3.
5
Long non-coding RNA in Non-alcoholic fatty liver disease.长链非编码 RNA 与非酒精性脂肪性肝病。
Adv Clin Chem. 2022;110:1-35. doi: 10.1016/bs.acc.2022.06.001. Epub 2022 Aug 31.
6
Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.二甲双胍诱导非酒精性脂肪性肝病小鼠肝脏中编码转录组和非编码RNA的变化
Cell Physiol Biochem. 2018;45(4):1487-1505. doi: 10.1159/000487575. Epub 2018 Feb 16.
7
Hammerhead-type FXR agonists induce an enhancer RNA that ameliorates nonalcoholic steatohepatitis in mice.锤头状法尼醇X受体激动剂可诱导一种增强子RNA,改善小鼠非酒精性脂肪性肝炎。
Elife. 2024 Apr 15;13:RP91438. doi: 10.7554/eLife.91438.
8
Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.非酒精性脂肪性肝病啮齿动物模型中的长链非编码RNA分析:对发病机制的新见解
Int J Mol Sci. 2017 Jan 16;18(1):21. doi: 10.3390/ijms18010021.
9
Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis.非酒精性脂肪性肝炎和肝纤维化中小鼠长链非编码单细胞转录组的失调。
RNA. 2023 Jul;29(7):977-1006. doi: 10.1261/rna.079580.123. Epub 2023 Apr 4.
10
Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease.核苷酸甲基化在代谢相关性脂肪性肝病中的作用研究进展。
Front Immunol. 2023 Mar 20;14:1148722. doi: 10.3389/fimmu.2023.1148722. eCollection 2023.

本文引用的文献

1
Decoding contextual crosstalk: revealing distinct interactions between non-coding RNAs and unfolded protein response in breast cancer.解码上下文串扰:揭示乳腺癌中非编码RNA与未折叠蛋白反应之间的独特相互作用
Cancer Cell Int. 2024 Mar 11;24(1):104. doi: 10.1186/s12935-024-03296-3.
2
ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway.ZNF143 通过靶向增加的 lncRNA NEAT1 表达来激活 ROCK2 通路,抑制肝细胞自噬,促进非酒精性脂肪性肝病。
Epigenetics. 2023 Dec;18(1):2239592. doi: 10.1080/15592294.2023.2239592.
3
Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
过氧化物酶体增殖物激活受体-γ 作为非酒精性脂肪性肝病中表观遗传机制的靶点和调节剂。
Cells. 2023 Apr 21;12(8):1205. doi: 10.3390/cells12081205.
4
Could Long Non-Coding RNA MEG3 and PTENP1 Interact with miR-21 in the Pathogenesis of Non-Alcoholic Fatty Liver Disease?长链非编码RNA MEG3和PTENP1在非酒精性脂肪性肝病发病机制中是否与miR-21相互作用?
Biomedicines. 2023 Feb 15;11(2):574. doi: 10.3390/biomedicines11020574.
5
Long Noncoding RNAs in the Pathogenesis of Insulin Resistance.长链非编码 RNA 在胰岛素抵抗发病机制中的作用。
Int J Mol Sci. 2022 Dec 16;23(24):16054. doi: 10.3390/ijms232416054.
6
LncRNA ZFAS1 ameliorates injury led by non-alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation.长链非编码RNA ZFAS1通过抑制脂质过氧化和炎症反应减轻非酒精性脂肪性肝病所致损伤。
Clin Res Hepatol Gastroenterol. 2023 Jan;47(1):102067. doi: 10.1016/j.clinre.2022.102067. Epub 2022 Dec 10.
7
LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.LINC01468通过与CUL4A相关的SHIP2降解驱动非酒精性脂肪性肝病-肝癌进展。
Cell Death Discov. 2022 Nov 7;8(1):449. doi: 10.1038/s41420-022-01234-8.
8
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.非编码RNA在非酒精性脂肪性肝病(NAFLD)相关肝细胞癌(HCC)的发生发展及演变过程中的意义
Int J Mol Sci. 2022 Oct 15;23(20):12370. doi: 10.3390/ijms232012370.
9
LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway.长链非编码 RNA GAS5 敲低可减轻肝脂质蓄积 通过调节 miR-26a-5p/PDE4B 激活 cAMP/CREB 通路。
Front Endocrinol (Lausanne). 2022 Jul 26;13:889858. doi: 10.3389/fendo.2022.889858. eCollection 2022.
10
Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中长链非编码RNA基因的系统分析
Noncoding RNA. 2022 Jul 22;8(4):56. doi: 10.3390/ncrna8040056.